Related Experiment Video
Updated: Jan 1, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.4K
Management of Hyperlipidemia After Stroke
Daniel C Brooks1, Joseph L Schindler2
1Department of Internal Medicine, Division of Neurology, Stamford Health Medical Group and Stamford Hospital, Stamford, CT, USA.
Current Treatment Options in Cardiovascular Medicine
|December 17, 2019
Summary
Hyperlipidemia management is crucial for stroke prevention. Statins are first-line, with PCSK9 inhibitors and ezetimibe offering additional stroke risk reduction when added to statins for high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Hyperlipidemia is a significant risk factor for stroke.
- Effective management of lipid levels is essential for cardiovascular health and stroke risk reduction.
Purpose of the Study:
- To review current treatment options for hyperlipidemia.
- To evaluate the efficacy of these treatments in preventing stroke, considering general cardiovascular disease and specific stroke subtypes (ischemic and hemorrhagic).
Main Methods:
- Literature review of clinical trials and studies on hyperlipidemia treatments.
- Analysis of treatment efficacy data, focusing on stroke risk reduction.
Main Results:
- Statins are the primary treatment for hyperlipidemia to prevent stroke.
- PCSK9 inhibitors and ezetimibe, when added to statins, provide further stroke risk reduction in patients with atherosclerotic vascular disease.
- Aggressive low-density lipoprotein cholesterol (LDL-C) reduction is key for high-risk patients.
Conclusions:
- Hyperlipidemia is a modifiable target for stroke risk reduction.
- Combination therapy with statins and novel agents like PCSK9 inhibitors or ezetimibe can significantly decrease stroke risk.
- Identifying patients who benefit from intensive lipid-lowering strategies is critical for stroke prevention.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
284
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
284
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:23Atherosclerosis IV: Nursing Management
313
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
313
01:26Angina IV: Management
199
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
199
01:26Coronary Artery Disease IV: Preventive Measures
547
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
547
01:27Peripheral Artery Disease III: Interprofessional Care
201
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
201